{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:04:54Z","timestamp":1723161894956},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Importance<\/jats:title>\n                <jats:p>Patients undergoing cancer treatment experience a multitude of skin, hair, and nail adverse events, prompting them to use non-evidence-based and often restrictive over-the-counter (OTC) recommendations to alleviate their symptoms. Comprehensively assessing evidence-based OTC modalities is crucial to enable cancer patients to comfortably resume their lives post-treatment and integrate clinically sound practices into their self-care routines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Perform a systematic review and assessment of evidence-based OTC skin, hair, and nail care recommendations for adult patients undergoing cancer treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Evidence review<\/jats:title>\n                <jats:p>PubMed, Cochrane, Embase, and Medline databases were searched in March 2023 to identify English articles addressing OTC skin, hair, and nail care recommendations for adult patients before, during, and after cancer chemotherapy or radiation therapy (RT). Quality was assessed with Oxford Centre for Evidence Based Medicine criteria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Findings<\/jats:title>\n                <jats:p>2192 unique articles were screened, of which 77 met inclusion criteria consisting of 54 randomized controlled trials (RCT), 8 non-randomized controlled cohorts, 1 non-randomized controlled clinical trial, 3 controlled prospective cohorts, 4 prospective cohorts, 2 controlled clinical trials, 1 prospective comparative study, 2 case reports, and 2 case series discussing 9322 patients. An additional article outside of our database search was included for a total of 78 articles. OTC skin care treatments with the best quality of evidence included moisturizing creams. Our review revealed a paucity of evidence-based hair and nail care practices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions and relevance<\/jats:title>\n                <jats:p>This systematic review serves to highlight the efficacy of diverse OTC skin, hair, and nail care recommendations for adult cancer patients while encouraging further clinical trials to establish evidence-based management guidelines.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-024-08735-5","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T02:02:06Z","timestamp":1723082526000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The validity of over-the-counter skin, hair, and nail recommendations for adult patients with cancer: A systematic review"],"prefix":"10.1007","volume":"32","author":[{"given":"Bahar","family":"Javdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay M.","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha A.","family":"Rangu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emely","family":"Tejeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth N.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"issue":"2","key":"8735_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/00001622-200203000-00012","volume":"14","author":"E Alley","year":"2002","unstructured":"Alley E, Green R, Schuchter L (2002) Cutaneous toxicities of cancer therapy. Curr Opin Oncol 14(2):212\u2013216. https:\/\/doi.org\/10.1097\/00001622-200203000-00012","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"8735_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00105-005-0971-0","volume":"56","author":"AL Branzan","year":"2005","unstructured":"Branzan AL, Landthaler M, Szeimies R-M (2005) [Skin changes with chemotherapy]. Hautarzt Z Dermatol Venerol Verwandte Geb 56(6):591\u2013602. https:\/\/doi.org\/10.1007\/s00105-005-0971-0. (quiz 603)","journal-title":"Hautarzt Z Dermatol Venerol Verwandte Geb"},{"issue":"6","key":"8735_CR3","first-page":"334","volume":"68","author":"K Zarrabi","year":"2019","unstructured":"Zarrabi K, Gemmill JAL, Safaee M, Baer L (2019) Managing dermatologic changes of targeted cancer therapy. J Fam Pract 68(6):334\u2013340","journal-title":"J Fam Pract"},{"key":"8735_CR4","unstructured":"Bouhanna P (2021) Alopecia after certain cancer treatments. Dermatologie Pratique. https:\/\/www.eyecare.fr\/img\/cms\/outils\/Hors%20se%CC%81rie-septembre%202021-version-anglaise-BD-2.pdf"},{"issue":"8","key":"8735_CR5","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3390\/healthcare10081496","volume":"10","author":"DW Sherman","year":"2022","unstructured":"Sherman DW, Walsh SM (2022) Promoting comfort: a clinician guide and evidence-based skin care plan in the prevention and management of radiation dermatitis for patients with breast cancer. Healthcare 10(8):1496. https:\/\/doi.org\/10.3390\/healthcare10081496","journal-title":"Healthcare"},{"key":"8735_CR6","volume-title":"Manual for Radiation Oncology Nursing Practice and Education","year":"2004","unstructured":"Bruner DW, Haas ML, Gosselin-Acomb TK (eds) (2004) Manual for Radiation Oncology Nursing Practice and Education, 3rd edn. Oncology Nursing Society, Pittsburgh, PA","edition":"3"},{"issue":"4","key":"8735_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3747\/co.v17i4.493","volume":"17","author":"N Salvo","year":"2010","unstructured":"Salvo N et al (2010) Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr Oncol Tor Ont 17(4):94\u2013112. https:\/\/doi.org\/10.3747\/co.v17i4.493","journal-title":"Curr Oncol Tor Ont"},{"issue":"3","key":"8735_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/annonc\/mdq387","volume":"22","author":"K Potthoff","year":"2011","unstructured":"Potthoff K et al (2011) Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion. Ann Oncol 22(3):524\u2013535. https:\/\/doi.org\/10.1093\/annonc\/mdq387","journal-title":"Ann Oncol"},{"key":"8735_CR9","doi-asserted-by":"publisher","first-page":"2020-4\u20137","DOI":"10.7573\/dic.2020-4-7","volume":"9","author":"NA Iacovelli","year":"2020","unstructured":"Iacovelli NA et al (2020) Topical treatment of radiation-induced dermatitis current issues and potential solutions. Drugs Context 9:2020-4\u20137. https:\/\/doi.org\/10.7573\/dic.2020-4-7","journal-title":"Drugs Context"},{"issue":"3","key":"8735_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2354.2001.00272.x","volume":"10","author":"D Batchelor","year":"2001","unstructured":"Batchelor D (2001) Hair and cancer chemotherapy: consequences and nursing care\u2013a literature study. Eur J Cancer Care (Engl) 10(3):147\u2013163. https:\/\/doi.org\/10.1046\/j.1365-2354.2001.00272.x","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"5","key":"8735_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg Lond Engl 8(5):336\u2013341. https:\/\/doi.org\/10.1016\/j.ijsu.2010.02.007","journal-title":"Int J Surg Lond Engl"},{"key":"8735_CR12","unstructured":"Ball C, Sackett D, Phillips B, Haynes B, Straus S (2009) Levels of evidence and grades of recommendations Oxford Centre for Evidence-Based Medicine. [Online]. Available:\u00a0https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009. Accessed 15 Mar 2023"},{"issue":"3","key":"8735_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/s0167-8140(00)00322-4","volume":"58","author":"I Roy","year":"2001","unstructured":"Roy I, Fortin A, Larochelle M (2001) The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol J Eur Soc Ther Radiol Oncol 58(3):333\u2013339. https:\/\/doi.org\/10.1016\/s0167-8140(00)00322-4","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"1","key":"8735_CR14","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.ijrobp.2011.12.006","volume":"83","author":"LC Watson","year":"2012","unstructured":"Watson LC, Gies D, Thompson E, Thomas B (2012) Randomized control trial: evaluating aluminum-based antiperspirant use, axilla skin toxicity, and reported quality of life in women receiving external beam radiotherapy for treatment of Stage 0, I, and II breast cancer. Int J Radiat Oncol Biol Phys 83(1):e29-34. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.12.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"8735_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.breast.2014.02.005","volume":"23","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ et al (2014) Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92\/08). Breast Edinb Scotl 23(3):244\u2013249. https:\/\/doi.org\/10.1016\/j.breast.2014.02.005","journal-title":"Breast Edinb Scotl"},{"issue":"6","key":"8735_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/00002820-200511000-00005","volume":"28","author":"SS Mak","year":"2005","unstructured":"Mak SS et al (2005) A comparison of wound treatments in nasopharyngeal cancer patients receiving radiation therapy. Cancer Nurs 28(6):436\u2013445. https:\/\/doi.org\/10.1097\/00002820-200511000-00005","journal-title":"Cancer Nurs"},{"issue":"3","key":"8735_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00002820-200006000-00010","volume":"23","author":"SS Mak","year":"2000","unstructured":"Mak SS, Molassiotis A, Wan WM, Lee IY, Chan ES (2000) The effects of hydrocolloid dressing and gentian violet on radiation-induced moist desquamation wound healing. Cancer Nurs 23(3):220\u2013229. https:\/\/doi.org\/10.1097\/00002820-200006000-00010","journal-title":"Cancer Nurs"},{"issue":"7","key":"8735_CR18","first-page":"1207","volume":"18","author":"A Yeomans","year":"1991","unstructured":"Yeomans A, Davitt M, Peters CA, Pastuszek C, Cobb S (1991) Efficacy of chlorhexidine gluconate use in the prevention of perirectal infections in patients with acute leukemia. Oncol Nurs Forum 18(7):1207\u20131213","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"8735_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0360-3016(01)01576-0","volume":"51","author":"E Szumacher","year":"2001","unstructured":"Szumacher E et al (2001) Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. Int J Radiat Oncol Biol Phys 51(1):81\u201386. https:\/\/doi.org\/10.1016\/s0360-3016(01)01576-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"8735_CR20","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/s0360-3016(00)00782-3","volume":"48","author":"J Fisher","year":"2000","unstructured":"Fisher J et al (2000) Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97\u201313. Int J Radiat Oncol Biol Phys 48(5):1307\u20131310. https:\/\/doi.org\/10.1016\/s0360-3016(00)00782-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"8735_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.radonc.2015.08.028","volume":"117","author":"L Bazire","year":"2015","unstructured":"Bazire L et al (2015) Hydrosorb\u00ae versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial. Radiother Oncol J Eur Soc Ther Radiol Oncol 117(2):229\u2013233. https:\/\/doi.org\/10.1016\/j.radonc.2015.08.028","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"5","key":"8735_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1188\/10.ONF.619-626","volume":"37","author":"TK Gosselin","year":"2010","unstructured":"Gosselin TK, Schneider SM, Plambeck MA, Rowe K (2010) A prospective randomized, placebo-controlled skin care study in women diagnosed with breast cancer undergoing radiation therapy. Oncol Nurs Forum 37(5):619\u2013626. https:\/\/doi.org\/10.1188\/10.ONF.619-626","journal-title":"Oncol Nurs Forum"},{"issue":"13","key":"8735_CR23","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1200\/JCO.2005.04.9148","volume":"24","author":"EA Elliott","year":"2006","unstructured":"Elliott EA et al (2006) Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99\u201313. J Clin Oncol Off J Am Soc Clin Oncol 24(13):2092\u20132097. https:\/\/doi.org\/10.1200\/JCO.2005.04.9148","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"8735_CR24","doi-asserted-by":"publisher","first-page":"102230","DOI":"10.1016\/j.ejon.2022.102230","volume":"61","author":"FM Queiroz Schmidt","year":"2022","unstructured":"Queiroz Schmidt FM, Serna Gonz\u00e1lez CV, Mattar RC, Lopes LB, Santos MF, de Gouveia Santos VLC (2022) Topical application of a cream containing nanoparticles with vitamin E for radiodermatitis prevention in women with breast cancer: A randomized, triple-blind, controlled pilot trial. Eur J Oncol Nurs Soc 61:102230. https:\/\/doi.org\/10.1016\/j.ejon.2022.102230","journal-title":"Eur J Oncol Nurs Soc"},{"issue":"22","key":"8735_CR25","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1200\/JCO.2014.60.4587","volume":"33","author":"R-D Hofheinz","year":"2015","unstructured":"Hofheinz R-D et al (2015) Mapisal versus urea cream as prophylaxis for capecitabine-associated hand-foot syndrome: a randomized phase III trial of the AIO quality of life working group. J Clin Oncol Off J Am Soc Clin Oncol 33(22):2444\u20132449. https:\/\/doi.org\/10.1200\/JCO.2014.60.4587","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"8735_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12094-010-0465-0","volume":"12","author":"J Pardo Masferrer","year":"2010","unstructured":"Pardo Masferrer J et al (2010) Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 12(1):43\u201348. https:\/\/doi.org\/10.1007\/s12094-010-0465-0","journal-title":"Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"issue":"3","key":"8735_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jmrs.397","volume":"67","author":"J Yan","year":"2020","unstructured":"Yan J et al (2020) Mepitel Film is superior to Biafine cream in managing acute radiation-induced skin reactions in head and neck cancer patients: a randomised intra-patient controlled clinical trial. J Med Radiat Sci 67(3):208\u2013216. https:\/\/doi.org\/10.1002\/jmrs.397","journal-title":"J Med Radiat Sci"},{"issue":"3","key":"8735_CR28","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ijrobp.2003.11.031","volume":"59","author":"T Vuong","year":"2004","unstructured":"Vuong T et al (2004) Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. Int J Radiat Oncol Biol Phys 59(3):809\u2013814. https:\/\/doi.org\/10.1016\/j.ijrobp.2003.11.031","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"8735_CR29","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/j.ijrobp.2012.03.062","volume":"84","author":"TM Niazi","year":"2012","unstructured":"Niazi TM et al (2012) Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study. Int J Radiat Oncol Biol Phys 84(3):e305-310. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.03.062","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"8735_CR30","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.12968\/bjon.2014.23.Sup10.S24","volume":"23","author":"A Scott","year":"2014","unstructured":"Scott A (2014) Polymeric membrane dressings for radiotherapy-induced skin damage. Br J Nurs Mark 23(10):S24\u2013S26-31. https:\/\/doi.org\/10.12968\/bjon.2014.23.Sup10.S24","journal-title":"Br J Nurs Mark"},{"issue":"1","key":"8735_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0360-3016(03)01431-7","volume":"58","author":"P Graham","year":"2004","unstructured":"Graham P et al (2004) Randomized, paired comparison of No-Sting Barrier Film versus sorbolene cream (10% glycerine) skin care during postmastectomy irradiation. Int J Radiat Oncol Biol Phys 58(1):241\u2013246. https:\/\/doi.org\/10.1016\/s0360-3016(03)01431-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"8735_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijrobp.2015.10.053","volume":"95","author":"T Arimura","year":"2016","unstructured":"Arimura T et al (2016) Effect of film dressing on acute radiation dermatitis secondary to proton beam therapy. Int J Radiat Oncol Biol Phys 95(1):472\u2013476. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.10.053","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"8735_CR33","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/0284186X.2018.1441542","volume":"57","author":"LC Schmeel","year":"2018","unstructured":"Schmeel LC et al (2018) Prophylactically applied Hydrofilm polyurethane film dressings reduce radiation dermatitis in adjuvant radiation therapy of breast cancer patients. Acta Oncol Stockh Swed 57(7):908\u2013915. https:\/\/doi.org\/10.1080\/0284186X.2018.1441542","journal-title":"Acta Oncol Stockh Swed"},{"key":"8735_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.radonc.2019.07.014","volume":"139","author":"RJ Chan","year":"2019","unstructured":"Chan RJ et al (2019) A single-blind, randomised controlled trial of StrataXRT\u00ae - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol 139:72\u201378. https:\/\/doi.org\/10.1016\/j.radonc.2019.07.014","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"4","key":"8735_CR35","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s12032-013-0761-y","volume":"30","author":"W-H Zhong","year":"2013","unstructured":"Zhong W-H, Tang Q-F, Hu L-Y, Feng H-X (2013) Mepilex Lite dressings for managing acute radiation dermatitis in nasopharyngeal carcinoma patients: a systematic controlled clinical trial. Med Oncol Northwood Lond Engl 30(4):761. https:\/\/doi.org\/10.1007\/s12032-013-0761-y","journal-title":"Med Oncol Northwood Lond Engl"},{"issue":"3","key":"8735_CR36","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ijrobp.2006.12.049","volume":"68","author":"MS Macmillan","year":"2007","unstructured":"Macmillan MS, Wells M, MacBride S, Raab GM, Munro A, MacDougall H (2007) Randomized comparison of dry dressings versus hydrogel in management of radiation-induced moist desquamation. Int J Radiat Oncol Biol Phys 68(3):864\u2013872. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.12.049","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"8735_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.clbc.2014.12.006","volume":"15","author":"D Hoopfer","year":"2015","unstructured":"Hoopfer D et al (2015) Three-arm randomized phase III trial: quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy. Clin Breast Cancer 15(3):181-190.e1\u20134. https:\/\/doi.org\/10.1016\/j.clbc.2014.12.006","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"8735_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/00002820-200212000-00007","volume":"25","author":"S Heggie","year":"2002","unstructured":"Heggie S et al (2002) A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 25(6):442\u2013451. https:\/\/doi.org\/10.1097\/00002820-200212000-00007","journal-title":"Cancer Nurs"},{"issue":"4","key":"8735_CR39","first-page":"233","volume":"103","author":"DM Siegel","year":"2019","unstructured":"Siegel DM, Jakus J, Hooper D (2019) Topical natural products in managing dermatologic conditions: observations and recommendations. Cutis 103(4):233-236 E1;E2","journal-title":"Cutis"},{"issue":"7","key":"8735_CR40","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1007\/s00520-019-05166-5","volume":"28","author":"J Ryan Wolf","year":"2020","unstructured":"Ryan Wolf J et al (2020) Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 28(7):3303\u20133311. https:\/\/doi.org\/10.1007\/s00520-019-05166-5","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"1","key":"8735_CR41","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1111\/ajd.13434","volume":"62","author":"S Siddiquee","year":"2021","unstructured":"Siddiquee S et al (2021) Efficacy of topical Calendula officinalis on prevalence of radiation-induced dermatitis: A randomised controlled trial. Australas J Dermatol 62(1):e35\u2013e40. https:\/\/doi.org\/10.1111\/ajd.13434","journal-title":"Australas J Dermatol"},{"issue":"7","key":"8735_CR42","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamadermatol.2022.1736","volume":"158","author":"H Zhao","year":"2022","unstructured":"Zhao H et al (2022) Efficacy of epigallocatechin-3-gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy: a double-blind, placebo-controlled, phase 2 randomized clinical trial. JAMA Dermatol 158(7):779\u2013786. https:\/\/doi.org\/10.1001\/jamadermatol.2022.1736","journal-title":"JAMA Dermatol"},{"issue":"1","key":"8735_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clcc.2013.10.001","volume":"13","author":"F Pinta","year":"2014","unstructured":"Pinta F et al (2014) Pilot clinical trial on the efficacy of prophylactic use of vitamin K1-based cream (Vigorskin) to prevent cetuximab-induced skin rash in patients with metastatic colorectal cancer. Clin Colorectal Cancer 13(1):62\u201367. https:\/\/doi.org\/10.1016\/j.clcc.2013.10.001","journal-title":"Clin Colorectal Cancer"},{"issue":"7","key":"8735_CR44","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00520-017-3623-x","volume":"25","author":"JG Eriksen","year":"2017","unstructured":"Eriksen JG, Kaalund I, Clemmensen O, Overgaard J, Pfeiffer P (2017) Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 25(7):2179\u20132185. https:\/\/doi.org\/10.1007\/s00520-017-3623-x","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"2","key":"8735_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0167-8140(99)00146-2","volume":"54","author":"C Westbury","year":"2000","unstructured":"Westbury C, Hines F, Hawkes E, Ashley S, Brada M (2000) Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial. Radiother Oncol J Eur Soc Ther Radiol Oncol 54(2):109\u2013116. https:\/\/doi.org\/10.1016\/s0167-8140(99)00146-2","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"4","key":"8735_CR46","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s00520-019-04982-z","volume":"28","author":"D Kang","year":"2020","unstructured":"Kang D et al (2020) Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT). Support Care Cancer Off J Multinatl Assoc Support Care Cancer 28(4):1829\u20131837. https:\/\/doi.org\/10.1007\/s00520-019-04982-z","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"1","key":"8735_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0190-9622(96)90500-9","volume":"35","author":"M Duvic","year":"1996","unstructured":"Duvic M et al (1996) A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 35(1):74\u201378. https:\/\/doi.org\/10.1016\/S0190-9622(96)90500-9","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"8735_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00520-008-0475-4","volume":"17","author":"F Mols","year":"2009","unstructured":"Mols F, van den Hurk CJ, Vingerhoets AJJM, Breed WPM (2009) Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 17(2):181\u2013189. https:\/\/doi.org\/10.1007\/s00520-008-0475-4","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"6","key":"8735_CR49","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00520-003-0451-y","volume":"11","author":"M Ridderheim","year":"2003","unstructured":"Ridderheim M, Bjurberg M, Gustavsson A (2003) Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 11(6):371\u2013377. https:\/\/doi.org\/10.1007\/s00520-003-0451-y","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"9","key":"8735_CR50","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00520-013-1804-9","volume":"21","author":"DC Betticher","year":"2013","unstructured":"Betticher DC et al (2013) Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 21(9):2565\u20132573. https:\/\/doi.org\/10.1007\/s00520-013-1804-9","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"12","key":"8735_CR51","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00520-012-1465-0","volume":"20","author":"CJG van den Hurk","year":"2012","unstructured":"van den Hurk CJG, Breed WPM, Nortier JWR (2012) Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 20(12):3255\u20133260. https:\/\/doi.org\/10.1007\/s00520-012-1465-0","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"5","key":"8735_CR52","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00520-018-4432-6","volume":"27","author":"MMC Komen","year":"2019","unstructured":"Komen MMC et al (2019) Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 27(5):1919\u20131925. https:\/\/doi.org\/10.1007\/s00520-018-4432-6","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"5","key":"8735_CR53","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00520-013-2095-x","volume":"22","author":"AL McCarthy","year":"2014","unstructured":"McCarthy AL, Shaban RZ, Gillespie K, Vick J (2014) Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 22(5):1375\u20131383. https:\/\/doi.org\/10.1007\/s00520-013-2095-x","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"19","key":"8735_CR54","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","volume":"23","author":"F Scott\u00e9","year":"2005","unstructured":"Scott\u00e9 F et al (2005) Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol Off J Am Soc Clin Oncol 23(19):4424\u20134429. https:\/\/doi.org\/10.1200\/JCO.2005.15.651","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"8735_CR55","doi-asserted-by":"publisher","first-page":"11575","DOI":"10.1038\/s41598-022-13327-6","volume":"12","author":"A Morrison","year":"2022","unstructured":"Morrison A et al (2022) A randomised controlled trial of interventions for taxane-induced nail toxicity in women with early breast cancer. Sci Rep 12(1):11575. https:\/\/doi.org\/10.1038\/s41598-022-13327-6","journal-title":"Sci Rep"},{"issue":"12","key":"8735_CR56","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1001\/jamaoncol.2018.4292","volume":"4","author":"BC Baumann","year":"2018","unstructured":"Baumann BC et al (2018) Assessing the validity of clinician advice that patients avoid use of topical agents before daily radiotherapy treatments. JAMA Oncol 4(12):1742\u20131748. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4292","journal-title":"JAMA Oncol"},{"issue":"5","key":"8735_CR57","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.amjsurg.2005.02.001","volume":"189","author":"T MikoEnomoto","year":"2005","unstructured":"MikoEnomoto T, Johnson T, Peterson N, Homer L, Walts D, Johnson N (2005) Combination glutathione and anthocyanins as an alternative for skin care during external-beam radiation. Am J Surg 189(5):627\u2013630. https:\/\/doi.org\/10.1016\/j.amjsurg.2005.02.001. (discussion 630\u2013631)","journal-title":"Am J Surg"},{"issue":"1","key":"8735_CR58","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00520-011-1110-3","volume":"20","author":"H Abbas","year":"2012","unstructured":"Abbas H, Bensadoun R-J (2012) Trolamine emulsion for the prevention of radiation dermatitis in patients with squamous cell carcinoma of the head and neck. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 20(1):185\u2013190. https:\/\/doi.org\/10.1007\/s00520-011-1110-3","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"8735_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103811","volume":"99","author":"A Ayati","year":"2020","unstructured":"Ayati A, Moghimi S, Salarinejad S, Safavi M, Pouramiri B, Foroumadi A (2020) A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. Bioorganic Chem 99:103811. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103811","journal-title":"Bioorganic Chem"},{"issue":"12","key":"8735_CR60","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1634\/theoncologist.2016-0051","volume":"21","author":"R-D Hofheinz","year":"2016","unstructured":"Hofheinz R-D et al (2016) Recommendations for the prophylactic management of skin reactions induced by epidermal growth factor receptor inhibitors in patients with solid tumors. Oncologist 21(12):1483\u20131491. https:\/\/doi.org\/10.1634\/theoncologist.2016-0051","journal-title":"Oncologist"},{"issue":"1","key":"8735_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1684\/ejd.2012.1899","volume":"23","author":"J-C Jo","year":"2013","unstructured":"Jo J-C et al (2013) Topical vitamin K1 may not be effective in preventing acneiform rash during cetuximab treatment in patients with metastatic colorectal cancer. Eur J Dermatol EJD 23(1):77\u201382. https:\/\/doi.org\/10.1684\/ejd.2012.1899","journal-title":"Eur J Dermatol EJD"},{"issue":"6","key":"8735_CR62","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00432-017-2344-3","volume":"143","author":"CC Schimanski","year":"2017","unstructured":"Schimanski CC et al (2017) Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care. J Cancer Res Clin Oncol 143(6):1023\u20131034. https:\/\/doi.org\/10.1007\/s00432-017-2344-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"8735_CR63","first-page":"543","volume":"28","author":"DL Olsen","year":"2001","unstructured":"Olsen DL et al (2001) The effect of aloe vera gel\/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy. Oncol Nurs Forum 28(3):543\u2013547","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"8735_CR64","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","volume":"15","author":"SC Gupta","year":"2012","unstructured":"Gupta SC, Patchva S, Aggarwal BB (2012) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15(1):195\u2013218. https:\/\/doi.org\/10.1208\/s12248-012-9432-8","journal-title":"AAPS J"},{"key":"8735_CR65","first-page":"70","volume":"148\u2013149","author":"A Korakhashvili","year":"2007","unstructured":"Korakhashvili A, Kacharava T, Kiknavelidze N (2007) Biochemical structure of Calendula officinalis. Georgian Med News 148\u2013149:70\u201373","journal-title":"Georgian Med News"},{"issue":"3","key":"8735_CR66","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/1541-4337.12346","volume":"17","author":"M Nikoo","year":"2018","unstructured":"Nikoo M, Regenstein JM, Ahmadi Gavlighi H (2018) Antioxidant and Antimicrobial Activities of (-)-Epigallocatechin-3-gallate (EGCG) and its potential to preserve the quality and safety of foods. Compr Rev Food Sci Food Saf 17(3):732\u2013753. https:\/\/doi.org\/10.1111\/1541-4337.12346","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"4","key":"8735_CR67","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","volume":"71","author":"KK Miller","year":"2014","unstructured":"Miller KK, Gorcey L, McLellan BN (2014) Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol 71(4):787\u2013794. https:\/\/doi.org\/10.1016\/j.jaad.2014.03.019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"8735_CR68","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.coc.0000026486.56886.18","volume":"26","author":"J Childress","year":"2003","unstructured":"Childress J, Lokich J (2003) Cutaneous hand and foot toxicity associated with cancer chemotherapy. Am J Clin Oncol 26(5):435\u2013436. https:\/\/doi.org\/10.1097\/01.coc.0000026486.56886.18","journal-title":"Am J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08735-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T02:03:07Z","timestamp":1723082587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08735-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["8735"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08735-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"577"}}